
### [MONDO:0013099](http://purl.obolibrary.org/obo/MONDO_0013099)
**Label:** combined pituitary hormone deficiencies, genetic forms

**Subclasses:** [MONDO:0013518](http://purl.obolibrary.org/obo/MONDO_0013518) (pituitary hormone deficiency, combined, 6), [MONDO:0009878](http://purl.obolibrary.org/obo/MONDO_0009878) (pituitary hormone deficiency, combined, 2), [MONDO:0008428](http://purl.obolibrary.org/obo/MONDO_0008428) (septooptic dysplasia), 

**Mapped go classes:** [GO:0008022](http://purl.obolibrary.org/obo/GO_0008022) (protein C-terminus binding), [GO:0007492](http://purl.obolibrary.org/obo/GO_0007492) (endoderm development), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0043584](http://purl.obolibrary.org/obo/GO_0043584) (nose development), [GO:0060126](http://purl.obolibrary.org/obo/GO_0060126) (somatotropin secreting cell differentiation), [GO:0009953](http://purl.obolibrary.org/obo/GO_0009953) (dorsal/ventral pattern formation), [GO:0030426](http://purl.obolibrary.org/obo/GO_0030426) (growth cone), [GO:0000980](http://purl.obolibrary.org/obo/GO_0000980) (RNA polymerase II distal enhancer sequence-specific DNA binding), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0030901](http://purl.obolibrary.org/obo/GO_0030901) (midbrain development), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0030902](http://purl.obolibrary.org/obo/GO_0030902) (hindbrain development), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0003406](http://purl.obolibrary.org/obo/GO_0003406) (retinal pigment epithelium development), [GO:0001708](http://purl.obolibrary.org/obo/GO_0001708) (cell fate specification), [GO:0032525](http://purl.obolibrary.org/obo/GO_0032525) (somite rostral/caudal axis specification), [GO:0042706](http://purl.obolibrary.org/obo/GO_0042706) (eye photoreceptor cell fate commitment), [GO:0021549](http://purl.obolibrary.org/obo/GO_0021549) (cerebellum development), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:0021984](http://purl.obolibrary.org/obo/GO_0021984) (adenohypophysis development), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0001158](http://purl.obolibrary.org/obo/GO_0001158) (enhancer sequence-specific DNA binding), [GO:0022037](http://purl.obolibrary.org/obo/GO_0022037) (metencephalon development), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0048852](http://purl.obolibrary.org/obo/GO_0048852) (diencephalon morphogenesis), [GO:0048850](http://purl.obolibrary.org/obo/GO_0048850) (hypophysis morphogenesis), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0047485](http://purl.obolibrary.org/obo/GO_0047485) (protein N-terminus binding), [GO:0006461](http://purl.obolibrary.org/obo/GO_0006461) (protein complex assembly), [GO:0021978](http://purl.obolibrary.org/obo/GO_0021978) (telencephalon regionalization), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0021979](http://purl.obolibrary.org/obo/GO_0021979) (hypothalamus cell differentiation), [GO:0048856](http://purl.obolibrary.org/obo/GO_0048856) (anatomical structure development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0001206](http://purl.obolibrary.org/obo/GO_0001206) (transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0001205](http://purl.obolibrary.org/obo/GO_0001205) (transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding), [GO:0048732](http://purl.obolibrary.org/obo/GO_0048732) (gland development), [GO:0048853](http://purl.obolibrary.org/obo/GO_0048853) (forebrain morphogenesis), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0040019](http://purl.obolibrary.org/obo/GO_0040019) (positive regulation of embryonic development), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0048664](http://purl.obolibrary.org/obo/GO_0048664) (neuron fate determination), [GO:0048663](http://purl.obolibrary.org/obo/GO_0048663) (neuron fate commitment), [GO:0097306](http://purl.obolibrary.org/obo/GO_0097306) (cellular response to alcohol), [GO:0060070](http://purl.obolibrary.org/obo/GO_0060070) (canonical Wnt signaling pathway), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0048709](http://purl.obolibrary.org/obo/GO_0048709) (oligodendrocyte differentiation), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0030917](http://purl.obolibrary.org/obo/GO_0030917) (midbrain-hindbrain boundary development), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:1990830](http://purl.obolibrary.org/obo/GO_1990830) (cellular response to leukemia inhibitory factor), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0071542](http://purl.obolibrary.org/obo/GO_0071542) (dopaminergic neuron differentiation), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0030916](http://purl.obolibrary.org/obo/GO_0030916) (otic vesicle formation), [GO:0045165](http://purl.obolibrary.org/obo/GO_0045165) (cell fate commitment), [GO:2000543](http://purl.obolibrary.org/obo/GO_2000543) (positive regulation of gastrulation), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0090009](http://purl.obolibrary.org/obo/GO_0090009) (primitive streak formation), 

**Class expressions from DL-Learner:**

- [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding) 53.45%
- Thing 53.44%
- [GO:2000543](http://purl.obolibrary.org/obo/GO_2000543) (positive regulation of gastrulation) 51.72%
- [GO:1990830](http://purl.obolibrary.org/obo/GO_1990830) (cellular response to leukemia inhibitory factor) 51.72%
- [GO:1990823](http://purl.obolibrary.org/obo/GO_1990823) (response to leukemia inhibitory factor) 51.72%
- [GO:0090009](http://purl.obolibrary.org/obo/GO_0090009) (primitive streak formation) 51.72%
- [GO:0060126](http://purl.obolibrary.org/obo/GO_0060126) (somatotropin secreting cell differentiation) 51.72%
- [GO:0048853](http://purl.obolibrary.org/obo/GO_0048853) (forebrain morphogenesis) 51.72%
- [GO:0048852](http://purl.obolibrary.org/obo/GO_0048852) (diencephalon morphogenesis) 51.72%
- [GO:0048850](http://purl.obolibrary.org/obo/GO_0048850) (hypophysis morphogenesis) 51.72%
- [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity) 51.72%
- [GO:0043584](http://purl.obolibrary.org/obo/GO_0043584) (nose development) 51.72%
- [GO:0035326](http://purl.obolibrary.org/obo/GO_0035326) (enhancer binding) 51.72%
- [GO:0032525](http://purl.obolibrary.org/obo/GO_0032525) (somite rostral/caudal axis specification) 51.72%
- [GO:0030917](http://purl.obolibrary.org/obo/GO_0030917) (midbrain-hindbrain boundary development) 51.72%


